Notices of Compliance, 2018
1,461 notices issued in 2018, newest first.
| Date | Products | Company | Submission |
|---|---|---|---|
| December 31, 2018 | JAMP ITRACONAZOLE ORAL SOLUTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 28, 2018 | DOXORUBICIN INJECTION, BP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 28, 2018 | XIGDUO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 28, 2018 | BYDUREON | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 28, 2018 | GPC-ZIPRASIDONE | Generic Partners (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 27, 2018 | NAT-ZOLMITRIPTAN | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 27, 2018 | VYZULTA | Bausch & Lomb Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 24, 2018 | VERKAZIA | Santen Incorporated | New Drug Submission (NDS) · Priority |
| December 24, 2018 | AG-RABEPRAZOLE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 24, 2018 | FULPHILA | BGP Pharma ULC | New Drug Submission (NDS) · Other |
| December 21, 2018 | DALACIN VAGINAL CREAM | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2018 | ROSUVASTATIN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| December 21, 2018 | RATIO-TOPISALIC | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 21, 2018 | APO-MYCOPHENOLATE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| December 21, 2018 | APO-OLMESARTAN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| December 21, 2018 | NAPROXEN CAPSULES 200 MG | Catalent Ontario Limited | New Drug Submission (NDS) · Labelling Only |
| December 21, 2018 | AVASTIN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2018 | FERRIPROX | Apopharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2018 | ACT OLMESARTAN HCT | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 21, 2018 | ACT OLMESARTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 21, 2018 | RUBY-FILL | Jubilant Draximage Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2018 | ADCETRIS | Seattle Genetics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2018 | YF-VAX | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2018 | CERETEC | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2018 | DEXVETIDINE | Modern Veterinary Therapeutics Llc | Abbreviated New Drug Submission (ANDS) · Other |
| December 20, 2018 | ROPINIROLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 20, 2018 | FIBRISTAL | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2018 | XTANDI | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| December 20, 2018 | PMS-VENLAFAXINE XR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 20, 2018 | INTELLI-SEVELAMER | Intellipharm Inc | New Drug Submission (NDS) · Admin |
| December 19, 2018 | TYPHIM VI | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2018 | LENVIMA | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2018 | OMEPRAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 19, 2018 | BRINEURA | Biomarin International Limited | New Drug Submission (NDS) · Priority-NAS |
| December 19, 2018 | CRESEMBA | Avir Pharma Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 19, 2018 | MAR-DILTIAZEM CD | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 18, 2018 | CYTOMEL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 18, 2018 | APO-LANSOPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 17, 2018 | CETROTIDE | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| December 17, 2018 | PENTASA | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 17, 2018 | ACH-ANASTROZOLE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 14, 2018 | PENTHROX | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| December 14, 2018 | NAT-ERLOTINIB | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 14, 2018 | BLEXTEN | Aralez Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| December 14, 2018 | RISPERIDONE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 13, 2018 | BIOTHRAX | Emergent Biodefense Operations Lansing Llc | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 13, 2018 | TARO-CLINDAMYCIN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 13, 2018 | ONGLYZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2018 | BUDESONIDE | Tillotts Pharma Gmbh | New Drug Submission (NDS) · Admin |
| December 12, 2018 | EXTRA STRENGTH ALLERGY RELIEF | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 12, 2018 | VORICONAZOLE FOR INJECTION | Neo Health Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 12, 2018 | ICLUSIG | Ariad Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2018 | AZITHROMYCIN FOR INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 12, 2018 | VORICONAZOLE FOR INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 12, 2018 | VORICONAZOLE FOR INJECTION | Neo Health Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 12, 2018 | MED-VORICONAZOLE | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 11, 2018 | SANDOZ TELMISARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 11, 2018 | TARO-CARBAMAZEPINE; TARO-CARBAMAZEPINE CHEWABLE TABLETS | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 11, 2018 | ORKAMBI | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Priority |
| December 10, 2018 | CIDR 1380 | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 10, 2018 | JAMP CLINDAMYCIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| December 10, 2018 | BOSULIF | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2018 | APO-ERLOTINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 7, 2018 | IMDUR | Mda Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2018 | ACH-PIOGLITAZONE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 7, 2018 | FLONASE ALLERGY RELIEF | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2018 | TRINTELLIX | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2018 | CERDELGA | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2018 | BUSCOPAN | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2018 | MYLAN-FLUCONAZOLE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 6, 2018 | ZYKADIA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2018 | CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP | Teligent Ou | Abbreviated New Drug Submission (ANDS) · Other |
| December 5, 2018 | CRYSVITA | Kyowa Kirin, Inc. | New Drug Submission (NDS) · Priority-NAS |
| December 4, 2018 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 4, 2018 | LANSOPRAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 4, 2018 | APO-DESVENLAFAXINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 4, 2018 | PMS-NITROFURANTOIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 3, 2018 | ZAXINE | Salix Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 3, 2018 | APO-ESOMEPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 3, 2018 | MINT-ARIPIPRAZOLE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 30, 2018 | MINT-DONEPEZIL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2018 | CLINDAMYCIN INJECTION | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2018 | SOMAVERT | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2018 | MINT-OLANZAPINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2018 | MICTORYL; MICTORYL PEDIATRIC | Duchesnay Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2018 | SAIZEN | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2018 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| November 29, 2018 | DERMOTIC OIL EAR DROPS | Hill Dermaceuticals, Inc. | Supplement to a New Drug Submission (SNDS) · Labelling Only |
| November 29, 2018 | DIVIGEL (0.5 MG PACK); DIVIGEL (1 MG PACK); DIVIGEL(0.25 MG PACK) | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| November 29, 2018 | ADVIL GEL CAPLETS | Pfizer Consumer Healthcare, a division of Pfizer Canada ULC | Supplement to a New Drug Submission (SNDS) · Other |
| November 29, 2018 | STRAMUCIN | Glenmark Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Other |
| November 29, 2018 | BELSOMRA | Merck Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 29, 2018 | PRO-CIPROFLOXACIN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| November 29, 2018 | REPATHA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 29, 2018 | ACETAMINOPHEN INJECTION | Avir Pharma Inc | New Drug Submission (NDS) · Other |
| November 28, 2018 | TEVA-LATANOPROST | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| November 28, 2018 | RAN-FENTANYL MATRIX PATCH | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 28, 2018 | PRO-QUETIAPINE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| November 28, 2018 | LYSODREN | Laboratoire Hra Pharma | New Drug Submission (NDS) · Admin |
| November 28, 2018 | INHIBACE PLUS | Cheplapharm Arzneimittel Gmbh Germany | New Drug Submission (NDS) · Admin |
| November 28, 2018 | PRIVA-RAMIPRIL | Pharmapar Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 28, 2018 | SURMAX PREMIX | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2018 | RANITIDINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2018 | IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION | Mda Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 28, 2018 | OPSUMIT | Janssen Inc. | New Drug Submission (NDS) · Admin |
| November 28, 2018 | ACTEMRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2018 | UNITUXIN | United Therapeutics Corporation | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 27, 2018 | AG-GLICLAZIDE MR | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 27, 2018 | APO-AMOXI | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| November 27, 2018 | DARZALEX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 26, 2018 | MAVIRET | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| November 26, 2018 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 26, 2018 | BYDUREON BCISE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 26, 2018 | SUFENTANIL CITRATE INJECTION | Teligent Ou | Abbreviated New Drug Submission (ANDS) · Other |
| November 23, 2018 | METFORMIN FC | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 23, 2018 | UPTRAVI | Janssen Inc. | New Drug Submission (NDS) · Admin |
| November 23, 2018 | ZAVESCA | Janssen Inc. | New Drug Submission (NDS) · Admin |
| November 23, 2018 | TRACLEER | Janssen Inc. | New Drug Submission (NDS) · Admin |
| November 23, 2018 | CARIPUL | Janssen Inc. | New Drug Submission (NDS) · Admin |
| November 23, 2018 | IPG-PANTOPRAZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 23, 2018 | PRIVA-PERINDOPRIL ERBUMINE | Pharmapar Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 23, 2018 | PMS-PROGESTERONE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 23, 2018 | ALPROLIX | Bioverativ Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 23, 2018 | PANTOPRAZOLE SODIUM FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 23, 2018 | TARO-BOSENTAN | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 23, 2018 | MIRENA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 23, 2018 | ACCEL-RIZATRIPTAN ODT | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 23, 2018 | ILUVIEN | Knight Therapeutics Inc. | New Drug Submission (NDS) · Other |
| November 23, 2018 | HERCEPTIN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 23, 2018 | GAZYVA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 23, 2018 | PRACETAM 40% O.S. | Ceva Animal Health Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2018 | TARO-IMIQUIMOD; TARO-IMIQUIMOD PUMP | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 22, 2018 | GLEEVEC | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2018 | PRACETAM 20% O.S | Ceva Animal Health Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 21, 2018 | SUBLOCADE | Indivior Uk Limited | New Drug Submission (NDS) · Priority |
| November 21, 2018 | AG-MONTELUKAST | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 21, 2018 | BARACLUDE | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| November 21, 2018 | ADYNOVATE | Shire Pharma Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 20, 2018 | ADCETRIS | Seattle Genetics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 20, 2018 | JAMP-CANDESARTAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 20, 2018 | PEMETREXED DISODIUM FOR INJECTION USP | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 20, 2018 | MAR-MONTELUKAST | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 19, 2018 | JAYDESS | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 19, 2018 | DOXORUBICIN INJECTION, BP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 16, 2018 | CETIRIZINE HYDROCHLORIDE CAPSULES | Catalent Ontario Limited | Abbreviated New Drug Submission (ANDS) · Other |
| November 16, 2018 | PRIVA-ATORVASTATIN | Pharmapar Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 16, 2018 | M-PERINDOPRIL ERBUMINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 15, 2018 | M-ZOPICLONE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2018 | VARITHENA | Provensis Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2018 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| November 14, 2018 | KYLEENA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 14, 2018 | GEMCITABINE INJECTION | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 13, 2018 | SUROLAN | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 9, 2018 | CANESTEN 1 DAY INTERNAL CREAM; CANESTEN 3 DAY INTERNAL CREAM; CANESTEN 6 DAY INTERNAL CREAM; CANESTEN COMBI 1 DAY COMFORTAB + EXTERNAL CREAM; CANESTEN COMBI 1 DAY INTERNAL + EXTERNAL CREAMS; CANESTEN COMBI 3 DAY COMFORTAB + EXTERNAL CREAM | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 9, 2018 | STELARA; STELARA I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 9, 2018 | DELSTRIGO | Merck Canada Inc | New Drug Submission (NDS) · Other |
| November 9, 2018 | LIDOCAINE HYDROCHLORIDE INJECTION USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Labelling Only |
| November 9, 2018 | ZIAGEN | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 9, 2018 | PANTOPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 8, 2018 | EXTRA STRENGTH IBUPROFEN LIQUID CAPSULES; IBUPROFEN LIQUID CAPSULES | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2018 | PMS-NITROFURANTOIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2018 | KEVZARA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2018 | SANDOZ AMOXI-CLAV TABLET | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 8, 2018 | MATULANE | Leadiant Biosciences, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2018 | ZOLEDRONIC ACID INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2018 | KUVAN | Biomarin Pharmaceutical Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 7, 2018 | NIASTASE RT | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 7, 2018 | KAMRAB | Kamada Ltd | New Drug Submission (NDS) · Other |
| November 7, 2018 | EXPERIOR | Elanco Canada Limited | New Drug Submission (NDS) · Other |
| November 7, 2018 | GABAPENTIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| November 7, 2018 | JAMP-ZOLEDRONIC ACID | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| November 7, 2018 | TUSSIONEX | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 7, 2018 | GILENYA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| November 6, 2018 | REVOLUTION PLUS | Zoetis Canada Inc | New Drug Submission (NDS) · Other |
| November 6, 2018 | PLAVIX | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 6, 2018 | APO-FLUOXETINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 6, 2018 | SABRIL | Lundbeck Pharmaceuticals Llc | Supplement to a New Drug Submission (SNDS) · Other |
| November 6, 2018 | SECTRAL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 6, 2018 | RENFLEXIS | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| November 6, 2018 | SIMPONI; SIMPONI I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 6, 2018 | OCTAGAM 10%; OCTAGAM 5% | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| November 6, 2018 | AURO-AZITHROMYCIN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 5, 2018 | PRECEDEX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 5, 2018 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 5, 2018 | RIVA-LEVETIRACETAM | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 5, 2018 | APO-CLOMIPRAMINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 2, 2018 | SERTRALINE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| November 2, 2018 | TEVA-DOXYCYCLINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 2, 2018 | JANUMET; JANUMET XR | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 2, 2018 | JANUVIA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2018 | TILMICOSIN AC | Bio Agri Mix Lp | Abbreviated New Drug Submission (ANDS) · Other |
| November 1, 2018 | JAMP-VARDENAFIL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| November 1, 2018 | APO-VARDENAFIL | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 1, 2018 | MYLAN-VARDENAFIL | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| October 31, 2018 | SPECTRO ECZEMACARE MEDICATED CREAM | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2018 | ZOPICLONE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 31, 2018 | NRA-DULOXETINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 30, 2018 | REVESTIVE | Shire Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 30, 2018 | VENLAFAXINE XR | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| October 30, 2018 | NRA-CLOPIDOGREL | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 30, 2018 | RAPAMUNE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 30, 2018 | PROLEUKIN | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 29, 2018 | APO-DOXAZOSIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 29, 2018 | M-CINACALCET | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 29, 2018 | DULOXETINE | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| October 29, 2018 | DUTASTERIDE CAPSULES | Strides Pharma Global Pte. Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 29, 2018 | VANCOMYCIN HYDROCHLORIDE CAPSULES, USP | Strides Pharma Global Pte. Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 29, 2018 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 29, 2018 | VALCYTE | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 29, 2018 | AG-ALLOPURINOL | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 26, 2018 | PEDIACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2018 | TD ADSORBED | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2018 | ATACAND PLUS | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2018 | ATACAND | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2018 | HAEGARDA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2018 | ENTRESTO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2018 | ZOSTAVAX II | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2018 | FOLOTYN | Servier Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 25, 2018 | KYPROLIS | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2018 | ONDANSETRON INJECTION BP | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2018 | ASTRI-UC | Ecolab Co. | New Drug Submission (NDS) · Admin |
| October 24, 2018 | APO-PRAMIPEXOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2018 | COVERSYL PLUS HD | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2018 | SANDOZ MOMETASONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 22, 2018 | OLANZAPINE; OLANZAPINE ODT | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| October 22, 2018 | MINT-CIPROFLOX | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 22, 2018 | SANDOZ-CARBAMAZEPINE CR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2018 | APO-MIDODRINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| October 19, 2018 | CIPROFLOXACIN INJECTION | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2018 | ASTRI-IO-250 | Ecolab Co. | New Drug Submission (NDS) · Admin |
| October 18, 2018 | ONDANSETRON ODT | Sandoz Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| October 18, 2018 | PMS-IPRATROPIUM | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2018 | TEVA-IMATINIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2018 | JIVI | Bayer Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 17, 2018 | MACROBID | Allergan Inc | New Drug Submission (NDS) · Admin |
| October 17, 2018 | PLIAGLIS | Intega Sciences De La Peau | New Drug Submission (NDS) · Admin |
| October 17, 2018 | GD-VARENICLINE | Genmed A Division Of Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 17, 2018 | ELIQUIS | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2018 | AG-PERINDOPRIL | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 16, 2018 | NRA-EZETIMIBE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 16, 2018 | NAT-OMEPRAZOLE DR | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 16, 2018 | TARO-CAPECITABINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 16, 2018 | APO-PINDOL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2018 | AURO-DULOXETINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 16, 2018 | SANDOZ OLOPATADINE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2018 | ANAFRANIL | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2018 | INVOKAMET | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2018 | TASIGNA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2018 | AURO-CINACALCET | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 16, 2018 | SENSORCAINE; SENSORCAINE WITH EPINEPHRINE | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2018 | AFSTYLA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2018 | BOTOX | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2018 | REBINYN | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 15, 2018 | DOM-METFORMIN | Dominion Pharmacal | Supplement to a New Drug Submission (SNDS) · Admin |
| October 15, 2018 | ZESTRIL | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 15, 2018 | ZESTORETIC | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 15, 2018 | INVOKANA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 15, 2018 | APO-ATORVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2018 | PROTOPIC | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2018 | PERINDOPRIL ERBUMINE | Sanis Health Inc. | New Drug Submission (NDS) · Labelling Only |
| October 12, 2018 | MOVANTIK | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2018 | PIFELTRO | Merck Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 12, 2018 | LUVOX | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2018 | AERIUS | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2018 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2018 | BIO ASSURE | Sani-Marc Inc | New Drug Submission (NDS) · Admin |
| October 11, 2018 | OCALIVA | Intercept Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2018 | AG-PANTOPRAZOLE SODIUM | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 11, 2018 | CLOZAPINE TABLETS | Innomar Strategies Inc. | New Drug Submission (NDS) · Admin |
| October 11, 2018 | MEROPENEM FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2018 | TRAJENTA | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| October 10, 2018 | XERMELO | Ipsen Biopharmaceuticals Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 10, 2018 | DARZALEX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2018 | FLUCONAZOLE INJECTION; FLUCONAZOLE INJECTION SDZ | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 9, 2018 | APO-DEXTROAMPHETAMINE SR | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 5, 2018 | TEVA-GLATIRAMER ACETATE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Admin |
| October 5, 2018 | APO-CLINDAMYCIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 5, 2018 | RIVA-CYCLOBENZAPRINE | Laboratoire Riva Inc. | New Drug Submission (NDS) · Admin |
| October 5, 2018 | TRIMEBUTINE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 5, 2018 | PMS-FLUCONAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 5, 2018 | CIPROFLOXACIN INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 5, 2018 | CANESORAL; CANESORAL COMBI | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 5, 2018 | BYSTOLIC | Allergan Inc | New Drug Submission (NDS) · Labelling Only |
| October 5, 2018 | ORILISSA | AbbVie Corporation | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 4, 2018 | RIVA-CIPROFLOXACIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 4, 2018 | XELJANZ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 3, 2018 | FENTANYL CITRATE INJECTION USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| October 3, 2018 | RIVA-VENLAFAXINE XR | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 3, 2018 | TEGSEDI | Akcea Therapeutics Inc | New Drug Submission (NDS) · Priority-NAS |
| October 3, 2018 | AURO-CANDESARTAN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 3, 2018 | AG-TADALAFIL | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 3, 2018 | RADICAVA | Mitsubishi Tanabe Pharma Corporation | New Drug Submission (NDS) · Priority-NAS |
| October 3, 2018 | RYDAPT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 3, 2018 | VELTASSA | Vifor Fresenius Medical Care Renal Pharma Ltd | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 3, 2018 | DESLORATADINE TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 2, 2018 | TRIFEXIS | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 2, 2018 | PROPOFOL INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| October 2, 2018 | PROPOFOL-II INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| October 2, 2018 | AG-METOPROLOL-L | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 1, 2018 | PRAMIPEXOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 1, 2018 | ADACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 1, 2018 | CIPROFLOXACIN INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 1, 2018 | PHARMA-LACOSAMIDE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 1, 2018 | SANDOZ LACOSAMIDE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| October 1, 2018 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 1, 2018 | AURO-LACOSAMIDE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 1, 2018 | ALEMBIC-LACOSAMIDE | Alembic Pharmaceuticals Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 1, 2018 | APO-LACOSAMIDE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 1, 2018 | TEVA-LACOSAMIDE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 1, 2018 | PMS-LACOSAMIDE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 28, 2018 | DALACIN C PHOSPHATE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2018 | PREZCOBIX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2018 | LINEZOLID INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 28, 2018 | LEUCOVORIN CALCIUM INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2018 | FRAGMIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 27, 2018 | ZEMAIRA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 27, 2018 | GABAPENTIN CAPSULES USP; GABAPENTIN TABLETS USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 27, 2018 | MINT-DICLOFENAC | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 27, 2018 | JETREA | Thrombogenics Nv | New Drug Submission (NDS) · Admin |
| September 26, 2018 | OTOMAX | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2018 | ALECENSARO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2018 | AURO-TRANDOLAPRIL | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 26, 2018 | TEVA-TRANDOLAPRIL | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 25, 2018 | MAR-CIPROFLOXACIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 25, 2018 | AREPANRIX H5N1 | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2018 | ANAFRANIL | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2018 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2018 | BIO-ATORVASTATIN | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| September 25, 2018 | BIO-ESCITALOPRAM | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| September 25, 2018 | PRAMIPEXOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 25, 2018 | KETOROLAC TROMETHAMINE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2018 | PRECEDEX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2018 | AURO-ZOLMITRIPTAN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 21, 2018 | PANZYGA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2018 | TAFINLAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2018 | MEKINIST | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2018 | VENCLEXTA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Priority |
| September 21, 2018 | LINESSA 21; LINESSA 28 | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2018 | PRO-PIOGLITAZONE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 21, 2018 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2018 | AMIKACIN SULFATE INJECTION USP | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 20, 2018 | AMIODARONE HYDROCHLORIDE FOR INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 20, 2018 | OLMESARTAN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 20, 2018 | BIO-ZOPICLONE | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| September 20, 2018 | BIO-SILDENAFIL | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| September 20, 2018 | ACT TERBINAFINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 20, 2018 | METRONIDAZOLE INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2018 | APO-DARIFENACIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2018 | DUODOPA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2018 | MED-LATANOPROST-TIMOLOL | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2018 | MINT-ABACAVIR | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 20, 2018 | GIOTRIF | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2018 | ENROTRON 50 | Modern Veterinary Therapeutics Llc | Abbreviated New Drug Submission (ANDS) · Other |
| September 19, 2018 | ISENTRESS; ISENTRESS HD | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2018 | FLUMIST QUADRIVALENT | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2018 | TAKHZYRO | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Priority-NAS |
| September 19, 2018 | TALTZ | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 18, 2018 | TARO-PEMETREXED | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2018 | TEVA-ATORVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2018 | GLN-GABAPENTIN | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2018 | MEROPENEM FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2018 | XALKORI | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2018 | VOLTAREN EMULGEL BACK & MUSCLE PAIN | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2018 | KUVAN | Biomarin Pharmaceutical Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2018 | FETZIMA | Allergan Inc | New Drug Submission (NDS) · Labelling Only |
| September 14, 2018 | MAR-TRAMADOL | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 14, 2018 | ACTONEL DR | Allergan Pharma Co. | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2018 | XARELTO | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| September 14, 2018 | DUAVIVE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2018 | CABOMETYX | Ipsen Biopharmaceuticals Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| September 14, 2018 | TEVA-BETAHISTINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2018 | TEVA-CLINDAMYCIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 12, 2018 | SINEMET | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2018 | APTIOM | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2018 | CRINONE | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2018 | LOVENOX; LOVENOX HP | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2018 | HERCEPTIN SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2018 | CUBICIN RF | Cubist Pharmaceuticals Llc | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2018 | XELJANZ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2018 | HAVRIX 1440; HAVRIX 720 JUNIOR | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2018 | TWINRIX; TWINRIX JUNIOR | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2018 | DERMA-SMOOTHE/FS TOPICAL OIL | Hill Dermaceuticals, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2018 | INFLACAM CHEWABLE TABLETS | Chanelle Pharmaceuticals Manufacturing Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 10, 2018 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2018 | FLUVIRAL | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2018 | AG-PREGABALIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 10, 2018 | AG-AZITHROMYCIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 10, 2018 | FLUZONE QUADRIVALENT | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2018 | FLUZONE HIGH DOSE | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 7, 2018 | REMIFENTANIL HYDROCHLORIDE FOR INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 7, 2018 | ACTEMRA; ACTEMRA SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 7, 2018 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 7, 2018 | LUPRON DEPOT | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 7, 2018 | PMS-BUPRENORPHINE-NALOXONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 7, 2018 | AURO-DONEPEZIL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 7, 2018 | AURO-RAMIPRIL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 7, 2018 | APO-FAMOTIDINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 5, 2018 | INFLUVAC | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| September 5, 2018 | PREVACID; PREVACID FASTAB | Takeda Pharmaceuticals America Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 5, 2018 | STROMECTOL | Merck Canada Inc | New Drug Submission (NDS) · Other |
| September 5, 2018 | FUROSEMIDE INJECTION USP | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 5, 2018 | KYMRIAH | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Priority-NAS |
| September 5, 2018 | KYMRIAH | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Priority |
| September 4, 2018 | COUMADIN | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 4, 2018 | PERICHLOR | Pendopharm Division Of Pharmascience Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 4, 2018 | XYDALBA | Cipher Pharmaceuticals Inc. | New Drug Submission (NDS) · Priority-NAS |
| September 4, 2018 | SINEQUAN | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 4, 2018 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 4, 2018 | ACH-CANDESARTAN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 4, 2018 | FLUAD; FLUAD PEDIATRIC | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 4, 2018 | FEIBA NF | Shire Pharma Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 4, 2018 | DRAXXIN | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2018 | ELAVIL | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2018 | RIVA-CLONAZEPAM | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| August 31, 2018 | PRO-MIRTAZAPINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 31, 2018 | TEVA-OLANZAPINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 31, 2018 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 30, 2018 | FOMEPIZOLE FOR INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2018 | APO-VARENICLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2018 | TARO-PEMETREXED | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2018 | PERJETA; PERJETA-HERCEPTIN COMBO PACK | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2018 | RISEDRONATE-35 | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 29, 2018 | MITOMYCIN FOR INJECTION USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| August 29, 2018 | SOLIFENACIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 29, 2018 | GLN-TOPIRAMATE | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 29, 2018 | COSMEGEN | Recordati Rare Diseases Canada Inc | New Drug Submission (NDS) · Labelling Only |
| August 29, 2018 | APO-METHOTREXATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 29, 2018 | BAR-HYDROMORPHONE CR | Bard Pharmaceuticals (1990) Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2018 | AG-SILDENAFIL | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 29, 2018 | PRISTIQ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2018 | SIGNIFOR LAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2018 | TEVA-RAMIPRIL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 28, 2018 | CONSTELLA | Allergan Inc | New Drug Submission (NDS) · Labelling Only |
| August 28, 2018 | PEMETREXED DISODIUM FOR INJECTION | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 28, 2018 | SANDOZ MYCOPHENOLIC ACID | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2018 | MYLAN-OLANZAPINE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 28, 2018 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2018 | GLN-EZETIMIBE | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2018 | HYDROMORPHONE HYDROCHLORIDE INJECTION USP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 24, 2018 | TRISENOX | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 24, 2018 | TRISENOX | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 24, 2018 | VEMLIDY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 24, 2018 | MAR-CINACALCET | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 24, 2018 | BUSCOPAN | Sanofi Aventis | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2018 | REVIA | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 22, 2018 | PMS-PROGESTERONE | Pharmascience Inc. | New Drug Submission (NDS) · Other |
| August 22, 2018 | RAN-BUPROPION XL | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 22, 2018 | LARTRUVO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 20, 2018 | APO-ACYCLOVIR OINTMENT | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 20, 2018 | SOLIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Priority |
| August 20, 2018 | HANZEMA | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| August 17, 2018 | CLAVULIN | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2018 | SANDOZ EZETIMIBE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 17, 2018 | ALLERGY RELIEF; EXTRA STRENGTH ALLERGY RELIEF | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 17, 2018 | APO-LOPERAMIDE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2018 | OLUMIANT | Eli Lilly Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| August 17, 2018 | SANDOZ REPAGLINIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 16, 2018 | METOJECT SUBCUTANEOUS | Medexus Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2018 | TOBRAMYCIN FOR INJECTION USP | Sterimax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2018 | GAZYVA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2018 | ACCEL-ENTECAVIR | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 16, 2018 | CIMZIA | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2018 | LEUCOVORIN CALCIUM INJECTION | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 16, 2018 | NAT-AZACITIDINE | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 16, 2018 | NUCEIVA | Evolus Incorporated | New Drug Submission (NDS) · Other |
| August 15, 2018 | AG-SIMVASTATIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 15, 2018 | RIVA-METFORMIN | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| August 14, 2018 | SPINRAZA | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2018 | ZEULIDE DEPOT | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2018 | PMS-SALBUTAMOL | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2018 | MAR-METHIMAZOLE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 14, 2018 | M-RANITIDINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 14, 2018 | MYLAN-PALIPERIDONE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 14, 2018 | BUPIVACAINE INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 14, 2018 | TEVA-CLONIDINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2018 | BEXSERO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 13, 2018 | EDURANT | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2018 | LEUCOVORIN CALCIUM INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2018 | AZITHROMYCIN FOR INJECTION USP | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 10, 2018 | TEVA-PRAVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 10, 2018 | TARO-MELPHALAN | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 10, 2018 | SORIATANE | Allergan Inc | New Drug Submission (NDS) · Admin |
| August 10, 2018 | RIVA-OMEPRAZOLE DR | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 10, 2018 | CYSVIEW | BioSyent Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2018 | REPATHA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2018 | PERINDOPRIL ERBUMINE / INDAPAMIDE; PERINDOPRIL ERBUMINE / INDAPAMIDE HD | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Labelling Only |
| August 10, 2018 | MYCOPHENOLATE MOFETIL FOR INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 9, 2018 | ESBRIET | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2018 | ALEMBIC-TELMISARTAN/HCTZ | Alembic Pharmaceuticals Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| August 9, 2018 | M-OLMESARTAN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 9, 2018 | RIVA-FINASTERIDE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 9, 2018 | RIVA-RISEDRONATE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 8, 2018 | M-CLINDAMYCIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 8, 2018 | VISKEN | Aralez Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| August 8, 2018 | TEVA-ROSUVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 8, 2018 | AURO-TRAMADOL | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 8, 2018 | RIXUBIS | Shire Pharma Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 7, 2018 | NIPRIDE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 7, 2018 | CHILDREN'S ADVIL | Pfizer Consumer Healthcare, a division of Pfizer Canada ULC | Supplement to a New Drug Submission (SNDS) · Other |
| August 3, 2018 | ZOLEDRONIC ACID FOR INJECTION | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 3, 2018 | IMDUR | Mda Inc. | New Drug Submission (NDS) · Admin |
| August 3, 2018 | ACCEL-SILDENAFIL | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 3, 2018 | PERINDOPRIL ERBUMINE | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Labelling Only |
| August 3, 2018 | NIMENRIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 3, 2018 | GLEPTOSIL | Ceva Animal Health Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2018 | NRA-AZITHROMYCIN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 2, 2018 | NRA-CELECOXIB | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 2, 2018 | NRA-PAROXETINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 2, 2018 | FLUAD; FLUAD PEDIATRIC | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2018 | HEMLIBRA | Hoffmann-La Roche Limited | New Drug Submission (NDS) · Priority-NAS |
| August 1, 2018 | ETHACRYNATE SODIUM FOR INJECTION | Endo Par Innovation Company, Llc | Abbreviated New Drug Submission (ANDS) · Other |
| August 1, 2018 | OCTAGAM 10%; OCTAGAM 5% | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| August 1, 2018 | APO-PREGABALIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 1, 2018 | AIMOVIG | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| August 1, 2018 | MINT-ATORVASTATIN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| July 31, 2018 | JANUMET | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 31, 2018 | JANUVIA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 31, 2018 | APO-LORAZEPAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 31, 2018 | CLONAPAM | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2018 | IRBESARTAN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 30, 2018 | RIVA-ARIPIPRAZOLE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 30, 2018 | FIBRISTAL | Allergan Inc | New Drug Submission (NDS) · Admin |
| July 30, 2018 | SANDOZ FLUOXETINE | Sandoz Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| July 30, 2018 | OMEPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 30, 2018 | GPC-RIVASTIGMINE | Generic Partners (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 30, 2018 | PRAXBIND | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2018 | VIMOVO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2018 | TASIGNA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2018 | GPC-MODAFINIL | Generic Partners (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 27, 2018 | RITUXAN SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2018 | APO-CARVEDILOL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2018 | AURO-ELETRIPTAN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 26, 2018 | NINLARO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2018 | MYL-ESOMEPRAZOLE | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| July 26, 2018 | ALUNBRIG | Takeda Canada Incorporated | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 26, 2018 | TEVA-QUETIAPINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2018 | ADVATE | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Admin |
| July 25, 2018 | JAMP DICLOFENAC TOPICAL SOLUTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 25, 2018 | PMS-OMEPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 25, 2018 | ESTRAGYN VAGINAL CREAM | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 25, 2018 | RELISTOR | Salix Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 25, 2018 | ZOLEDRONIC ACID INJECTION | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 25, 2018 | JAMP-PREGABALIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 25, 2018 | LONGRANGE | Merial Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2018 | AGGRASTAT | Cipher Pharmaceuticals Inc. | New Drug Submission (NDS) · Admin |
| July 24, 2018 | BRINAVESS | Cipher Pharmaceuticals Inc. | New Drug Submission (NDS) · Admin |
| July 24, 2018 | APO-TOBRAMYCIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2018 | IMBRUVICA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| July 24, 2018 | JAMP-TENOFOVIR | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 24, 2018 | NUCYNTA IR | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2018 | NUCYNTA EXTENDED-RELEASE | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2018 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2018 | VETERGESIC MULTIDOSE | Ceva Animal Health Inc | New Drug Submission (NDS) · Admin |
| July 24, 2018 | RECONCILE | Pegasus Laboratories Inc | New Drug Submission (NDS) · Admin |
| July 24, 2018 | RECONCILE | Pegasus Laboratories Inc | New Drug Submission (NDS) · Admin |
| July 24, 2018 | RECONCILE | Pegasus Laboratories Inc | New Drug Submission (NDS) · Admin |
| July 24, 2018 | RECONCILE | Pegasus Laboratories Inc | New Drug Submission (NDS) · Admin |
| July 24, 2018 | VETONIXIN | Norbrook Laboratories Ltd. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 23, 2018 | ALEMBIC-TELMISARTAN | Alembic Pharmaceuticals Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 23, 2018 | XALACOM | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2018 | CYTOVENE | Cheplapharm Arzneimittel Gmbh Germany | New Drug Submission (NDS) · Admin |
| July 23, 2018 | GLYCOPYRROLATE INJECTION MULTIDOSE | Mont-Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 23, 2018 | ZIAGEN | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2018 | APO-ATAZANAVIR | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 23, 2018 | JAMP QUETIAPINE FUMARATE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| July 20, 2018 | JAMP GLICLAZIDE-MR | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| July 20, 2018 | APO-VALGANCICLOVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 20, 2018 | NRA-PREGABALIN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 20, 2018 | PEDIACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2018 | ACTACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2018 | PENTACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2018 | ACT-HIB | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2018 | SODIUM NITROPRUSSIDE FOR INJECTION | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 19, 2018 | APO-RISEDRONATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 19, 2018 | FLAGYL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2018 | TEPADINA | Adienne Sa | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2018 | APO-RISEDRONATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 18, 2018 | CEFTRIAXONE SODIUM FOR INJECTION BP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 18, 2018 | JAMP-RISPERIDONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 18, 2018 | ACCEL-ONDANSETRON | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 18, 2018 | APO-OLANZAPINE; APO-OLANZAPINE ODT | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 18, 2018 | ACCEL-LEFLUNOMIDE | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 18, 2018 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| July 17, 2018 | TRESIBA (FLEXTOUCH); TRESIBA (PENFILL) | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 17, 2018 | JAMP TOPIRAMATE TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| July 17, 2018 | JAMP TELMISARTAN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| July 17, 2018 | JAMP TELMISARTAN-HCT | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| July 17, 2018 | DOSTINEX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 17, 2018 | NUCALA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 16, 2018 | ROCURONIUM BROMIDE INJECTION | Mda Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 16, 2018 | APIDRA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 16, 2018 | LANTUS | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 13, 2018 | AG-PANTOPRAZOLE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 13, 2018 | SANDOZ MORPHINE SR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2018 | IPG-CIPROFLOXACIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2018 | GAMMAGARD S/D | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Admin |
| July 13, 2018 | ANTITHROMBIN III NF | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Admin |
| July 13, 2018 | PANHEMATIN | Recordati Rare Diseases Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| July 13, 2018 | JAMP-CHOLESTYRAMINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 12, 2018 | AURO-PRAMIPEXOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 12, 2018 | SANDOZ OLOPATADINE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2018 | NITRO-DUR 0.2; NITRO-DUR 0.4; NITRO-DUR 0.6; NITRO-DUR 0.8 | Uspharma Ltd | New Drug Submission (NDS) · Labelling Only |
| July 12, 2018 | SEVORANE AF | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2018 | CETROTIDE | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2018 | CYSTADANE | Recordati Rare Diseases Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2018 | SANDOZ TRANDOLAPRIL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 12, 2018 | SANDOZ TRANDOLAPRIL | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 12, 2018 | HIZENTRA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 11, 2018 | LOLO | Allergan Inc | New Drug Submission (NDS) · Admin |
| July 11, 2018 | EZETIMIBE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 11, 2018 | AG-OLMESARTAN HCTZ | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 11, 2018 | JAMP-ALENDRONATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 11, 2018 | AMLODIPINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 11, 2018 | PERJETA; PERJETA HERCEPTIN COMBO PACK | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2018 | PMS-ARIPIPRAZOLE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 10, 2018 | AURO-ARIPIPRAZOLE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 10, 2018 | TEVA-ARIPIPRAZOLE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| July 10, 2018 | BIKTARVY | Gilead Sciences Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 10, 2018 | SANDOZ ARIPIPRAZOLE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 10, 2018 | RAYALDEE | Vifor Fresenius Medical Care Renal Pharma Ltd | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 10, 2018 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| July 6, 2018 | JAMP RABEPRAZOLE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| July 6, 2018 | LOSEC | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2018 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Priority |
| July 6, 2018 | SOLIQUA | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Other |
| July 6, 2018 | CEPETOR | Modern Veterinary Therapeutics Llc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2018 | CIPROFLOXACIN INJECTION | Baxter Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| July 5, 2018 | REPATHA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2018 | GAZYVA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2018 | MYLAN-OSELTAMIVIR | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| July 5, 2018 | MENJUGATE | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 4, 2018 | MYLAN-RISPERIDONE ODT | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2018 | ZYDELIG | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 4, 2018 | BYDUREON | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 4, 2018 | AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 3, 2018 | APO-RAMIPRIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 3, 2018 | RANITIDINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 3, 2018 | NRA-TRAMADOL/ACET | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 3, 2018 | ERLEADA | Janssen Inc. | New Drug Submission (NDS) · Priority-NAS |
| July 3, 2018 | SANDOZ METFORMIN FC | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 29, 2018 | APO-ABACAVIR-LAMIVUDINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 29, 2018 | ONSIOR | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2018 | JAMP PANTOPRAZOLE SODIUM | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| June 29, 2018 | VISKEN | Tribute Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2018 | PRAXBIND | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2018 | JAMP REPAGLINIDE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| June 28, 2018 | MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2018 | AG-MOXIFLOXACIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 28, 2018 | AG-ATORVASTATIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 28, 2018 | APO-PINAVERIUM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2018 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 27, 2018 | SYMDEKO | Vertex Pharmaceuticals (Canada) Incorporated | New Drug Submission (NDS) · Priority-NAS |
| June 27, 2018 | ESCITALOPRAM | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 27, 2018 | PAROXETINE | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| June 27, 2018 | CELECOXIB | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| June 27, 2018 | AZITHROMYCIN | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| June 27, 2018 | AG-AMOXICILLIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 27, 2018 | AG-GABAPENTIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 27, 2018 | AG-SERTRALINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 27, 2018 | PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 27, 2018 | SANDOZ POLYTRIMETHOPRIM | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 26, 2018 | XIGDUO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2018 | OLIMEL 3.3 E; OLIMEL 4.4%; OLIMEL 4.4% E; OLIMEL 5.7%; OLIMEL 5.7% E; OLIMEL 7.6%; OLIMEL 7.6% E; PERIOLIMEL 2.5% E | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2018 | BUPIVACAINE INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 25, 2018 | ACCURETIC | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 25, 2018 | SANDOZ FENTANYL PATCH | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 25, 2018 | APO-LEVOFLOXACIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 25, 2018 | DALACIN C | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 25, 2018 | DALACIN C FLAVOURED GRANULES | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 25, 2018 | APTIOM | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 25, 2018 | DESCOVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 22, 2018 | APO-SALVENT IPRAVENT STERULES | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 22, 2018 | AG-ESCITALOPRAM | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 22, 2018 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 22, 2018 | NRA-CITALOPRAM | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 22, 2018 | MONOFERRIC | Pharmacosmos A | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 21, 2018 | AG-RAMIPRIL | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 20, 2018 | NRA-ROSUVASTATIN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 20, 2018 | IRINOTECAN HYDROCHLORIDE INJECTION USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 20, 2018 | PMS-METFORMIN | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 19, 2018 | GENVOYA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 19, 2018 | DICLOFENAC | Pharma Stulln Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 19, 2018 | PMS-DULOXETINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 19, 2018 | ACT VARENICLINE | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 19, 2018 | INVOKAMET XR | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 19, 2018 | ACT VARENICLINE | Actavis Pharma Company | Abbreviated New Drug Submission (ANDS) · Other |
| June 18, 2018 | NRA-ZOPICLONE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 18, 2018 | BRENZYS | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| June 18, 2018 | PROGRAM 40; PROGRAM 80 | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2018 | AG-ACET-TRAMADOL | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 15, 2018 | CRESTOR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2018 | RAN-PIOGLITAZONE | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2018 | TEVA-RAMIPRIL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2018 | PRIORIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2018 | 4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000; 4% ASTRACAINE DENTAL WITH EPINEPHRINE FORTE 1:100,000 | Dentsply Canada Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2018 | ENGERIX-B | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2018 | PMS-BUSULFAN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 14, 2018 | BRENZYS (PFP); BRENZYS (PFS) | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2018 | RHINOCORT TURBUHALER | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2018 | SYNOVEX CHOICE | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2018 | SYNOVEX PLUS | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 13, 2018 | FLUOXETINE | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Labelling Only |
| June 13, 2018 | JAMP-ESCITALOPRAM | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| June 13, 2018 | TEVA-IRBESARTAN HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 13, 2018 | ADCETRIS | Seattle Genetics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 12, 2018 | DIFLUCAN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 12, 2018 | ENTROPHEN CHEWABLE | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 12, 2018 | PRAXIS ASA EC 81 MG DAILY LOW DOSE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2018 | ANTIROBE | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 11, 2018 | TEVA-IRBESARTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 11, 2018 | VENCLEXTA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 11, 2018 | XYREM | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 11, 2018 | ALECENSARO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Priority |
| June 11, 2018 | LINCOCIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 11, 2018 | SALIX | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2018 | BIO-TRAMADOL/ACET | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| June 8, 2018 | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Labelling Only |
| June 8, 2018 | AURO-CEPHALEXIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 8, 2018 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2018 | FUNGIZONE | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2018 | APO-ACYCLOVIR OINTMENT | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 8, 2018 | PHARMA-ATORVASTATIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 8, 2018 | KYPROLIS | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2018 | PENICILLIN G PROCAINE 110 | Bio Agri Mix Lp | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2018 | METACAM 20 MG/ML SOLUTION FOR INJECTION | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2018 | BLINCYTO | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2018 | MINT-PIOGLITAZONE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 7, 2018 | INDIUM DTPA IN-111 | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2018 | TUDORZA GENUAIR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2018 | DUAKLIR GENUAIR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2018 | CAYSTON | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2018 | ODEFSEY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2018 | EUCRISA | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 6, 2018 | JAMP ZOLMITRIPTAN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| June 6, 2018 | CEFAZOLIN FOR INJECTION USP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 6, 2018 | AG-ROSUVASTATIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 6, 2018 | IBRANCE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2018 | AVASTIN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2018 | ZYKADIA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 5, 2018 | DOMPERIDONE | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| June 5, 2018 | JAMP PERINDOPRIL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| June 5, 2018 | ATORVASTATIN | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| June 5, 2018 | DACARBAZINE FOR INJECTION BP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2018 | TEVA-TOBRAMYCIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2018 | MINT-CANDESARTAN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 5, 2018 | REPATHA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2018 | RIVA-LETROZOLE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 4, 2018 | MINT-PERINDOPRIL | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 4, 2018 | NRA-ESCITALOPRAM | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 4, 2018 | TEVA-CEFADROXIL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 1, 2018 | SANDOZ PIOGLITAZONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 1, 2018 | NRA-SILDENAFIL | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 1, 2018 | AURO-AMOXICILLIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 1, 2018 | RESTASIS MULTIDOSE | Allergan Inc | New Drug Submission (NDS) · Other |
| June 1, 2018 | PMS-PROGESTERONE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 1, 2018 | EYLEA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2018 | AMINOSYN | Icu Medical Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2018 | MOVIPREP | Aralez Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| May 31, 2018 | NRA-ATORVASTATIN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 31, 2018 | FLAGYSTATIN | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2018 | AG-IRBESARTAN HCTZ | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 31, 2018 | AG-CIPROFLOXACIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 31, 2018 | APO-HYDROMORPHONE CR | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 31, 2018 | AURO-OLMESARTAN HCTZ | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 31, 2018 | FLUOROURACIL INJECTION | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 30, 2018 | AMINOSYN II | Icu Medical Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2018 | RIVA-ALENDRONATE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 30, 2018 | VISKAZIDE | Aralez Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| May 30, 2018 | PREGABALIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 30, 2018 | NRA-AMLODIPINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 30, 2018 | SEGLUROMET | Merck Canada Inc | New Drug Submission (NDS) · Other |
| May 29, 2018 | ACT PIOGLITAZONE | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2018 | AG-EZETIMIBE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 29, 2018 | APO-METHYLPHENIDATE ER | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2018 | GLYXAMBI | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2018 | ZYKADIA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 28, 2018 | M-PRAVASTATIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 28, 2018 | AG-ZOPICLONE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 28, 2018 | JAMP-RISEDRONATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 28, 2018 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 28, 2018 | MAR-FLECAINIDE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 28, 2018 | TORADOL | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2018 | APO-CEFUROXIME | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 24, 2018 | DARZALEX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 24, 2018 | AG-PRAVASTATIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 24, 2018 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 24, 2018 | DICLOFENAC SODIUM SOLUTION | Teligent Ou | Abbreviated New Drug Submission (ANDS) · Other |
| May 24, 2018 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 23, 2018 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 22, 2018 | APO-ADEFOVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 22, 2018 | AG-TOPIRAMATE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 22, 2018 | CAMBIA | Aralez Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| May 22, 2018 | JAMP-ACET-TRAMADOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 22, 2018 | CLINDAMYCINE-150; CLINDAMYCINE-300 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 22, 2018 | AG-QUETIAPINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 22, 2018 | AG-OLMESARTAN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 22, 2018 | TIVICAY | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 22, 2018 | STEGLUJAN | Merck Canada Inc | New Drug Submission (NDS) · Other |
| May 18, 2018 | KETOROLAC TROMETHAMINE INJECTION, USP | Mda Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 18, 2018 | IDELVION | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2018 | MEKINIST | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| May 18, 2018 | TAFINLAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| May 18, 2018 | SIMBRINZA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2018 | JULUCA | Viiv Healthcare Ulc | New Drug Submission (NDS) · Other |
| May 18, 2018 | TEVA-MOMETASONE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 18, 2018 | JAMP-CELECOXIB | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 18, 2018 | PMS-TRANDOLAPRIL | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 17, 2018 | DERMOTIC OIL EAR DROPS | Hill Dermaceuticals, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2018 | NIX DERMAL CREAM | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2018 | PRALUENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2018 | PMS-CLONAZEPAM | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2018 | ESCITALOPRAM | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| May 17, 2018 | HALAGON | Emdoka Bvba | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2018 | AGGRASTAT | Correvio (Uk) Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2018 | CEFOXITIN FOR INJECTION USP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2018 | CEFTRIAXONE FOR INJECTION USP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2018 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2018 | TEVA-FLUCONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2018 | ACT BORTEZOMIB | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2018 | ULTRACAINE D-S FORTE INJECTION; ULTRACAINE D-S INJECTION | Hansamed Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2018 | PMS-PIOGLITAZONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2018 | PRALUENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2018 | ENTROPHEN | Pendopharm Division Of De Pharmascience Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 14, 2018 | APO-PIOGLITAZONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 14, 2018 | MAXIMUM STRENGTH PEPCID AC; PEPCID AC | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2018 | PEPCID COMPLETE | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2018 | GLN-OLMESARTAN HCTZ | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 11, 2018 | ALPHANATE | Grifols Biologicals Llc | New Drug Submission (NDS) · Other |
| May 11, 2018 | PMS-CLONAZEPAM-R | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2018 | MERREM; MERREM (ADD-VANTAGE VIALS) | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| May 11, 2018 | APO-AMLODIPINE-ATORVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2018 | MYFORTIC | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2018 | KINERET | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2018 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2018 | DERMA-SMOOTHE/FS TOPICAL OIL | Hill Dermaceuticals, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2018 | HUMALOG | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2018 | BASAGLAR | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2018 | XARELTO | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 9, 2018 | PLAN B | Foundation Consumer Healthcare, Llc | New Drug Submission (NDS) · Labelling Only |
| May 9, 2018 | AG-PAROXETINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 9, 2018 | STEGLATRO | Merck Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| May 8, 2018 | HADLIMA; HADLIMA PUSHTOUCH | Samsung Bioepis Co., Ltd | New Drug Submission (NDS) · Other |
| May 8, 2018 | HADLIMA; HADLIMA PUSHTOUCH | Samsung Bioepis Co., Ltd | New Drug Submission (NDS) · Other |
| May 8, 2018 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| May 8, 2018 | WILATE | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| May 8, 2018 | GAMUNEX | Grifols Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2018 | TEVA-MOMETASONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 7, 2018 | ATENOLOL | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| May 7, 2018 | NRA-PANTOPRAZOLE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 4, 2018 | ARIXTRA | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2018 | FLUCONAZOLE INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 4, 2018 | GAMMAGARD LIQUID | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Admin |
| May 4, 2018 | OBIZUR | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Admin |
| May 4, 2018 | ACT AMLODIPINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| May 4, 2018 | RISPERDAL; RISPERDAL M-TAB | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2018 | AVANDIA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2018 | AG-DULOXETINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 4, 2018 | IMFINZI | Astrazeneca Canada Inc | New Drug Submission (NDS) · Other |
| May 4, 2018 | BAVENCIO | Emd Serono A Division Of Emd Inc Canada | New Drug Submission (NDS) · Other |
| May 4, 2018 | JAMP-METOPROLOL-L | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 4, 2018 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2018 | APO-AMBRISENTAN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 4, 2018 | GANCICLOVIR FOR INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 3, 2018 | TARO-DEFERASIROX | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 2, 2018 | KALETRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2018 | RESTORIL | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2018 | DONEPEZIL | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 2, 2018 | ENALAPRIL | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 2, 2018 | RIVA-ANASTROZOLE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 2, 2018 | GANCICLOVIR FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 2, 2018 | ACT METHYLPHENIDATE ER | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 2, 2018 | AMOXICILLIN | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2018 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2018 | SANDOZ CLOPIDOGREL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2018 | NASACORT ALLERGY 24HR | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2018 | CLARITIN ALLERGY + SINUS EXTRA STRENGTH | Bayer Inc Consumer Care | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2018 | NAPROXEN SODIUM CAPSULES | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 30, 2018 | MVASI | Amgen Canada Inc | New Drug Submission (NDS) · Other |
| April 30, 2018 | ADMELOG | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2018 | PMS-MOXIFLOXACIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 27, 2018 | PEMETREXED | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 27, 2018 | TEVA-ROSUVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 27, 2018 | ADVAIR; ADVAIR DISKUS | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2018 | MINT-DICLOFENAC | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| April 27, 2018 | STELARA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2018 | ACH-ALENDRONATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 26, 2018 | DANTRIUM CAPSULES | Endo Par Innovation Company, Llc | New Drug Submission (NDS) · Labelling Only |
| April 26, 2018 | COPAXONE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 26, 2018 | SOFRACORT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 26, 2018 | RAMIPRIL | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| April 26, 2018 | FINASTERIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 26, 2018 | LINEZOLID INJECTION | Neo Health Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 26, 2018 | SUPREFACT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 26, 2018 | APO-CLOBETASOL SPRAY | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 26, 2018 | FEIBA NF | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Admin |
| April 24, 2018 | DYSPORT AESTHETIC | Ipsen Biopharm Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2018 | ACT LEVETIRACETAM | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 24, 2018 | OXEZE TURBUHALER | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2018 | DANTRIUM INTRAVENOUS | Endo Par Innovation Company, Llc | New Drug Submission (NDS) · Labelling Only |
| April 24, 2018 | DOTAREM | Guerbet | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2018 | SANDOZ OMEPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 24, 2018 | JAMP-MOXIFLOXACIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 24, 2018 | TERBINAFINE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| April 24, 2018 | ATORVASTATIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 24, 2018 | NORDITROPIN NORDIFLEX | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2018 | DICLOFENAC | Eberth Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| April 23, 2018 | RANITIDINE | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| April 23, 2018 | BUSULFAN FOR INJECTION | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 23, 2018 | APO-BETAHISTINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 20, 2018 | CUVITRU | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Admin |
| April 20, 2018 | ADYNOVATE | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Admin |
| April 20, 2018 | IMMUNINE VH | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Admin |
| April 20, 2018 | ONCASPAR | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Admin |
| April 20, 2018 | SANDOZ PRAMIPEXOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 20, 2018 | GLYXAMBI | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2018 | MAXIDOL LIQUID GELS | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2018 | SANDOZ PERINDOPRIL ERBUMINE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| April 19, 2018 | ACT ESCITALOPRAM | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| April 19, 2018 | TRIAMCINOLONE HEXACETONIDE INJECTABLE SUSPENSION | Medexus Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2018 | NASACORT AQ | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2018 | VIROPTIC | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2018 | LATUDA | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2018 | APO-AMLODIPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 18, 2018 | ACT DORZOTIMOLOL | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| April 18, 2018 | XTANDI | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2018 | GENOTROPIN MINIQUICK | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2018 | PROBUPHINE | Knight Therapeutics Inc. | New Drug Submission (NDS) · Other |
| April 17, 2018 | ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION | Pierrel Pharma S.R.L. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| April 16, 2018 | MYLAN-PIOGLITAZONE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 16, 2018 | PANTOPRAZOLE SODIUM FOR INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 16, 2018 | JARDIANCE | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| April 16, 2018 | PRIVIGEN | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2018 | AURO-ATORVASTATIN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 13, 2018 | MAGNEVIST | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2018 | ILEVRO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2018 | RIXUBIS | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Admin |
| April 13, 2018 | ENBREL | Immunex Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2018 | NESINA | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2018 | EFICUR | Laboratorios Hipra S.A. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2018 | TEVA-DOMPERIDONE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Admin |
| April 12, 2018 | METHOTREXATE INJECTION BP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2018 | ELIQUIS | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2018 | NAT-OSELTAMIVIR | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2018 | CEREZYME | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2018 | TEVA-LAMIVUDINE/ZIDOVUDINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2018 | FUCITHALMIC | Amdipharm Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2018 | EYLEA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2018 | MOMETAMAX | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2018 | FORTEKOR FLAVOR TABS | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2018 | JAMP-SILDENAFIL R | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 12, 2018 | ZOPICLONE | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| April 12, 2018 | FUCIBET | Leo Pharma Inc | New Drug Submission (NDS) · Other |
| April 11, 2018 | XULTOPHY | Novo Nordisk Canada Inc | New Drug Submission (NDS) · Other |
| April 11, 2018 | CYSTADANE | Recordati Rare Diseases Canada Inc | New Drug Submission (NDS) · Labelling Only |
| April 11, 2018 | MAR-PERINDOPRIL | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 11, 2018 | BIO ASSURE | Wood Wyant Inc | New Drug Submission (NDS) · Other |
| April 10, 2018 | ENTOCORT | Tillotts Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| April 10, 2018 | APO-ARIPIPRAZOLE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 10, 2018 | JAMP ENALAPRIL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| April 10, 2018 | PREGABALIN | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| April 10, 2018 | ONIVYDE | Shire Pharma Canada Ulc | New Drug Submission (NDS) · Admin |
| April 10, 2018 | AG-LOSARTAN HCTZ | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 9, 2018 | PANTOPRAZOLE SODIUM FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 9, 2018 | SANDOZ AMOXICILLIN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 9, 2018 | AVASTIN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2018 | NUCYNTA IR | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2018 | SYNAGIS | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2018 | COMPONENT TE-S IMPLANTS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| April 9, 2018 | COMPONENT TE-H IMPLANTS | Elanco Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| April 9, 2018 | COMPONENT TE-G IMPLANTS | Elanco Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| April 9, 2018 | COMPONENT TE-200 IMPLANTS | Elanco Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| April 9, 2018 | COMPONENT E-S IMPLANTS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| April 9, 2018 | COMPONENT E-H IMPLANTS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| April 9, 2018 | COMPONENT E-C IMPLANTS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| April 7, 2018 | PENTHROX | Purdue Pharma | New Drug Submission (NDS) · Other |
| April 6, 2018 | PMS-PERINDOPRIL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 6, 2018 | CIPROFLOXACIN INJECTION USP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 6, 2018 | ARBESDA RESPICLICK | Teva Canada Limited | New Drug Submission (NDS) · Other |
| April 6, 2018 | ZOVIRAX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2018 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2018 | FORCYL | Vetoquinol N A Inc | New Drug Submission (NDS) · Other |
| April 6, 2018 | IMMITICIDE STERILE POWDER | Merial Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2018 | ALPROLIX | Bioverativ Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2018 | ISOVUE 200 INJECTION; ISOVUE 300 INJECTION; ISOVUE 370 INJECTION; ISOVUE MULTIPACK-300; ISOVUE MULTIPACK-370 | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2018 | SIMPONI I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2018 | LAPELGA | Apotex Inc. | New Drug Submission (NDS) · Other |
| April 4, 2018 | ERIVEDGE | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2018 | MINT-KETOROLAC | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 4, 2018 | DEXTROAMPHETAMINE | AA Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| April 4, 2018 | XGEVA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2018 | TRELEGY ELLIPTA | Glaxosmithkline Inc | New Drug Submission (NDS) · Other |
| April 3, 2018 | LEVETIRACETAM | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 29, 2018 | TALTZ | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 29, 2018 | DULOXETINE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| March 29, 2018 | ASACOL | Allergan Inc | New Drug Submission (NDS) · Admin |
| March 29, 2018 | APO-TACROLIMUS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 29, 2018 | TEVA-RISEDRONATE/CALCIUM | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 28, 2018 | OCEANBLU | DeLaval, Inc. | New Drug Submission (NDS) · Other |
| March 28, 2018 | METOPROLOL TARTRATE INJECTION USP | Mda Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 28, 2018 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2018 | FORXIGA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 28, 2018 | AG-IRBESARTAN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 28, 2018 | COMFORTIS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 28, 2018 | COMFORTIS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 28, 2018 | COMFORTIS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 28, 2018 | COMFORTIS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 28, 2018 | COMFORTIS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 28, 2018 | COMFORTIS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 28, 2018 | TRIFEXIS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 28, 2018 | TRIFEXIS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 28, 2018 | TRIFEXIS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 28, 2018 | TRIFEXIS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 28, 2018 | TRIFEXIS | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 27, 2018 | ORFADIN | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2018 | PMS-DEFERASIROX | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 26, 2018 | RIVA-ESCITALOPRAM | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 26, 2018 | MEMANTINE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 26, 2018 | MARCAINE | Septodont | Abbreviated New Drug Submission (ANDS) · Admin |
| March 26, 2018 | ZORCAINE | Septodont | New Drug Submission (NDS) · Admin |
| March 26, 2018 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2018 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2018 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2018 | ASACOL 800 | Allergan Inc | New Drug Submission (NDS) · Admin |
| March 23, 2018 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2018 | MOZOBIL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2018 | DOTAREM | Guerbet | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2018 | KAZANO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2018 | REKOVELLE | Ferring Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 22, 2018 | QTERN | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2018 | ONGLYZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2018 | KOMBOGLYZE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2018 | VERMOX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2018 | MIFEGYMISO | Linepharma International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2018 | TEVA-SALBUTAMOL HFA | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2018 | ALBAC 110 | Huvepharma Eood | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2018 | RITUXAN SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2018 | FYCOMPA | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2018 | LAMIVUDINE ORAL SOLUTION | Aurobindo Pharma Limited (Unit Iii) | Abbreviated New Drug Submission (ANDS) · Other |
| March 20, 2018 | MEZERA | Avir Pharma Inc | New Drug Submission (NDS) · Other |
| March 20, 2018 | SANDOZ GLICLAZIDE MR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| March 20, 2018 | ATRIPLA | Gilead Sciences, Inc. | New Drug Submission (NDS) · Admin |
| March 20, 2018 | NUWIQ | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2018 | INDERAL-LA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2018 | MAR-MIDODRINE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 19, 2018 | OXYTROL | Allergan Inc | New Drug Submission (NDS) · Admin |
| March 19, 2018 | ACT OLMESARTAN HCT | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| March 19, 2018 | APO-FINASTERIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 16, 2018 | CONTINGENCY ONE | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2018 | LUPRON; LUPRON DEPOT | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2018 | PMS-ZOLPIDEM ODT | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2018 | AURO-ZIPRASIDONE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 15, 2018 | MYLAN-ZIPRASIDONE | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| March 15, 2018 | CEFTRIAXONE SODIUM FOR INJECTION BP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 15, 2018 | ORENCIA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2018 | PLEGRIDY; PLEGRIDY (STARTER KIT) | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2018 | NAT-TENOFOVIR | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 15, 2018 | BESPONSA | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 14, 2018 | FLUMIST QUADRIVALENT | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2018 | MAR-CIDOFOVIR | Marcan Pharmaceuticals Inc. | New Drug Submission (NDS) · Other |
| March 14, 2018 | VULKETAN | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 14, 2018 | TARO-DOCETAXEL | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2018 | APO-CIPROFLOX | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2018 | JAYDESS | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2018 | ACH-LETROZOLE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 13, 2018 | IRINOTECAN HYDROCHLORIDE INJECTION USP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| March 13, 2018 | ESOMEPRAZOLE | Ethypharm Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 13, 2018 | VANECTYL-P | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2018 | SANDOZ TOPIRAMATE TABLETS | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| March 13, 2018 | APO-METFORMIN ER | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 12, 2018 | ALFENTANIL INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 12, 2018 | ZYKADIA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 12, 2018 | RAPAFLO | Allergan Inc | New Drug Submission (NDS) · Admin |
| March 12, 2018 | REDDY-PROGESTERONE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 12, 2018 | MINT-SILDENAFIL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 12, 2018 | GLYCOPYRROLATE INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 12, 2018 | JAMP-FOSFOMYCIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 12, 2018 | FLUOROURACIL INJECTION | Biolyse Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 9, 2018 | PROHANCE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2018 | MULTIHANCE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2018 | EYLEA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2018 | MOXIFLOXACIN INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2018 | DYSPORT THERAPEUTIC | Ipsen Biopharm Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2018 | APO-PERINDOPRIL ARGININE | Apotex Inc. | New Drug Submission (NDS) · Other |
| March 8, 2018 | AROMASIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2018 | ERAXIS | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2018 | TEVA-CYPROTERONE / ETHINYL ESTRADIOL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 8, 2018 | GADOVIST 1.0 | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2018 | METRONIDAZOLE INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2018 | ZONOVATE | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2018 | ICLUSIG | Ariad Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2018 | SYMTUZA | Janssen Inc. | New Drug Submission (NDS) · Other |
| March 7, 2018 | PRECEDEX | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| March 7, 2018 | CYCLOBENZAPRINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 7, 2018 | CARVEDILOL | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 7, 2018 | ACT OLMESARTAN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| March 7, 2018 | VENLAFAXINE XR | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 7, 2018 | PRIORIX-TETRA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2018 | MYLAN-PERINDOPRIL ARGININE | Mylan Pharmaceuticals Ulc | New Drug Submission (NDS) · Other |
| March 7, 2018 | PMS-PERINDOPRIL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2018 | RIVA-PERINDOPRIL | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 7, 2018 | APO-PERINDOPRIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2018 | APO-PERINDOPRIL-INDAPAMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2018 | APO-PERINDOPRIL-INDAPAMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2018 | PMS-PERINDOPRIL | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 7, 2018 | TEVA-PERINDOPRIL | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 7, 2018 | TEVA-PERINDOPRIL/INDAPAMIDE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 7, 2018 | AURO-PERINDOPRIL | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 7, 2018 | APO-PERINDOPRIL-INDAPAMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2018 | MYLAN-PERINDOPRIL/INDAPAMIDE | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| March 7, 2018 | MYLAN-PERINDOPRIL ERBUMINE | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| March 7, 2018 | APO-PERINDOPRIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2018 | APO-PERINDOPRIL PLUS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 7, 2018 | SANDOZ CLARITHROMYCIN XL | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 6, 2018 | RECOTHROM | Mallinckrodt Hospital Products Inc | New Drug Submission (NDS) · Labelling Only |
| March 6, 2018 | CALF SCOUR TABLETS | Interprovincial Co-Op Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2018 | FACTREL | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2018 | ONSIOR | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2018 | SILIQ | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 5, 2018 | OMNISCAN | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2018 | CELSENTRI | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2018 | THALLOUS CHLORIDE TI 201 INJECTION | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2018 | BEVESPI AEROSPHERE | Astrazeneca Canada Inc | New Drug Submission (NDS) · Other |
| March 5, 2018 | LUXIQ | Mayne Pharma Inc | New Drug Submission (NDS) · Admin |
| March 5, 2018 | TOPOTECAN HYDROCHLORIDE FOR INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2018 | APO-LINEZOLID | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2018 | VERAPAMIL HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2018 | BLINCYTO | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2018 | HIBERIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2018 | INFANRIX HEXA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2018 | BOOSTRIX-POLIO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2018 | BOOSTRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 2, 2018 | IXIARO | Valneva Austria Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| March 2, 2018 | CHAMPIX; CHAMPIX (STARTER KIT) | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 2, 2018 | KISQALI | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 1, 2018 | GPC-LINEZOLID INJECTION | Generic Partners (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2018 | TEVA-CILAZAPRIL/HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 1, 2018 | TARO-CAPECITABINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2018 | PANZYGA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2018 | NEXGARD SPECTRA | Merial Canada Inc. | New Drug Submission (NDS) · Other |
| March 1, 2018 | DYSTOSEL | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2018 | TYLAN 100 | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 1, 2018 | TYLAN 40 | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| March 1, 2018 | TYLAN 10 | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 28, 2018 | DURATOCIN | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 28, 2018 | ANDRODERM | Allergan Inc | New Drug Submission (NDS) · Admin |
| February 28, 2018 | TYPHIM VI | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 28, 2018 | VIVAXIM | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 27, 2018 | DUODOPA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| February 27, 2018 | MYLAN-CIPROFLOXACIN | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2018 | OLUX-E | Mayne Pharma Inc | New Drug Submission (NDS) · Admin |
| February 27, 2018 | TIMOLOL | AA Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| February 27, 2018 | M-RANITIDINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 27, 2018 | APO-AMOXI | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 27, 2018 | ADDYI | Sprout Pharmaceuticals Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| February 27, 2018 | APO-TELMISARTAN-AMLODIPINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 26, 2018 | CLARO | Bayer Inc., Animal Health | New Drug Submission (NDS) · Other |
| February 23, 2018 | NAT-CITALOPRAM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2018 | MELPHALAN FOR INJECTION | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 23, 2018 | SANDOZ IRBESARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2018 | RAN-CIPROFLOX | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2018 | PMS-METHYLPHENIDATE ER | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2018 | M-DULOXETINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 22, 2018 | JAMP CANDESARTAN-HCT | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| February 22, 2018 | M-VALSARTAN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 22, 2018 | FASENRA | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| February 22, 2018 | AFLURIA TETRA | Seqirus Pty Ltd | New Drug Submission (NDS) · Other |
| February 21, 2018 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2018 | KADCYLA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2018 | PAMIDRONATE DISODIUM FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2018 | APO-TAMOX | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2018 | ACT BUPRENORPHINE/NALOXONE | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 19, 2018 | PROPECIA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2018 | APO-DABIGATRAN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 19, 2018 | APO-MOXIFLOXACIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 19, 2018 | PROSCAR | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2018 | NIMENRIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2018 | TEVA-DABIGATRAN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 19, 2018 | COMPUDOSE | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 19, 2018 | TYLAN 200 | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 19, 2018 | PULMOTIL PREMIX | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 16, 2018 | KALYDECO | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2018 | XARELTO | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2018 | VYLOMA | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2018 | VALCYTE | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2018 | OPTICROM | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2018 | BUSULFAN INJECTION | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 15, 2018 | COVERSYL | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2018 | AVAPRO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2018 | AVALIDE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2018 | PLAVIX | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2018 | INVEGA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2018 | APO-AMOXI SUGAR FREE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2018 | TYLAN 10 PREMIX; TYLAN 100 PREMIX; TYLAN 40 PREMIX | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2018 | CUTAQUIG | Octapharma Pharmazeutika Produktionsges M B H | New Drug Submission (NDS) · Other |
| February 14, 2018 | ESBRIET | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 14, 2018 | PMS-VARENICLINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 14, 2018 | APO-MINOCYCLINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 14, 2018 | PMS-VARENICLINE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 14, 2018 | KEVZARA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 14, 2018 | OCREVUS | Hoffmann-La Roche Limited | New Drug Submission (NDS) · Priority |
| February 14, 2018 | COMPONENT TE-H IMPLANTS WITH TYLAN | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 14, 2018 | COMPONENT E-H IMPLANTS WITH TYLAN | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 14, 2018 | COMPONENT E-C IMPLANTS WITH TYLAN | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 14, 2018 | COMPONENT TE-100 IMPLANTS WITH TYLAN | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 14, 2018 | COMPONENT TE-G IMPLANTS WITH TYLAN | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 14, 2018 | COMPONENT TE-200 IMPLANTS WITH TYLAN | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 14, 2018 | COMPONENT E-S IMPLANTS WITH TYLAN | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 14, 2018 | COMPONENT TE-S IMPLANTS WITH TYLAN | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 13, 2018 | ALLEGRA 12 HOUR; ALLEGRA 24 HOUR | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2018 | ZERIT | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2018 | ZYTIGA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| February 13, 2018 | PROLIA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2018 | FLUVIRAL | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2018 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2018 | CONTRAVE | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · Other |
| February 13, 2018 | VINORELBINE INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 12, 2018 | FIBRYGA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| February 9, 2018 | ZESTORETIC | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 9, 2018 | ORGARAN | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| February 9, 2018 | ZESTRIL | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 9, 2018 | FIASP | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 8, 2018 | NORFLOXACIN | AA Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| February 8, 2018 | EUTHANSOL-D | Intervet Canada Corp | New Drug Submission (NDS) · Other |
| February 8, 2018 | CHLOR 100 | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2018 | LINCOMIX | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 6, 2018 | ACT AMPHETAMINE XR | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| February 6, 2018 | JAKAVI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 6, 2018 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2018 | ZYKADIA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2018 | M-MOXIFLOXACIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 5, 2018 | ZYCLARA | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2018 | NAT-OSELTAMIVIR | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 5, 2018 | ZOLEDRONIC ACID FOR INJECTION | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 2, 2018 | APTIOM | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2018 | CYANOKIT | Serb S.A. | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2018 | LISINOPRIL | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| February 2, 2018 | LUPIN-ESTRADIOL | Lupin Pharma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2018 | ALDARA P | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2018 | APO-VARENICLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2018 | APO-TEMOZOLOMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2018 | APO-VARENICLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2018 | APO-VARENICLINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 2, 2018 | SOMATULINE AUTOGEL | Ipsen Biopharm Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2018 | CYCLOBENZAPRINE - 10 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| February 2, 2018 | GRASTOFIL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2018 | GRANISETRON HCL TABLETS | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 2, 2018 | PEMETREXED DISODIUM FOR INJECTION | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 2, 2018 | BLINCYTO | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2018 | APRALAN | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 2, 2018 | OVUGEL | United-Ah Ii Llc | New Drug Submission (NDS) · Admin |
| February 2, 2018 | SURMAX 200 PREMIX | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 2, 2018 | SURMAX 100 PREMIX | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 2, 2018 | TYLAN SOLUBLE | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 2, 2018 | SUROLAN | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 2, 2018 | RUMENSIN PREMIX | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 1, 2018 | TARO-CLINDAMYCIN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 1, 2018 | CIPROFLOXACIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 1, 2018 | PRO-LISINOPRIL - 10; PRO-LISINOPRIL - 20; PRO-LISINOPRIL - 5 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| February 1, 2018 | METOPROLOL-L | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| February 1, 2018 | LINESSA 21; LINESSA 28 | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| January 31, 2018 | REDDY-CINACALCET | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| January 30, 2018 | RELENZA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 30, 2018 | ETODOLAC CAPSULES BP | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 30, 2018 | BREO ELLIPTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 30, 2018 | OFIRMEV | Mallinckrodt Hospital Products Inc | New Drug Submission (NDS) · Admin |
| January 29, 2018 | PLAQUENIL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 29, 2018 | AUREOMYCIN 220 G | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 29, 2018 | DERACIN 22% GRANULAR PREMIX | Pharmgate Llc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 26, 2018 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2018 | BRICANYL TURBUHALER | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2018 | NUWIQ | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2018 | APO-LANSOPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 26, 2018 | RAMIPRIL | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 26, 2018 | ROTARIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2018 | JAMP-URSODIOL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 25, 2018 | ULTRAVATE CREAM | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2018 | COLD & SINUS RELIEF CAPSULES | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2018 | LONSURF | Taiho Pharma Canada, Inc. | New Drug Submission (NDS) · Priority-NAS |
| January 25, 2018 | LINCOMYCIN SOLUBLE POWDER | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 24, 2018 | DERMOTIC OIL EAR DROPS | Hill Dermaceuticals, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 24, 2018 | PMS-PANTOPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 23, 2018 | PROLOPA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 23, 2018 | APO-RABEPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 23, 2018 | JAMP-DICLOFENAC | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| January 23, 2018 | TARGIN | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | VALIUM | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | SEROQUEL; SEROQUEL XR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | CANDESARTAN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 22, 2018 | ACT DONEPEZIL ODT | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| January 22, 2018 | DENAGARD 10% GF PREMIX | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | DENAGARD 12.5% | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | TIAMULIN 1.78% | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 22, 2018 | TIAMULIN HF 10% | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 22, 2018 | TIAMULIN SOLUBLE POWDER | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 22, 2018 | VETMULIN LIQUID CONCENTRATE | Huvepharma Eood | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 22, 2018 | VETMULIN PREMIX | Huvepharma Eood | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 22, 2018 | DENAGARD | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | BMD 110 G | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | BMD SOLUBLE | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | ALBAC 110 | Huvepharma Eood | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | ZINC BACITRACIN 110 | Davis And Lawrence Co. | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | STAFAC 22 | Phibro Animal Health Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | STAFAC 44 | Phibro Animal Health Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | VIRGINIAMYCIN 44 | Bio Agri Mix Lp | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | STAFAC 500 | Phibro Animal Health Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2018 | BACITRACIN MD | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2018 | NPLATE | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2018 | EMPLICITI | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2018 | ACTOS | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2018 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2018 | CORIFACT 1250; CORIFACT 250 | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2018 | GABAPENTIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 19, 2018 | SANDOZ MYCOPHENOLATE MOFETIL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2018 | PROC PEN LA | Norbrook Laboratories Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | PRIVA-TRAMADOL/ACET | Pharmapar Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 18, 2018 | SANDOZ OLMESARTAN HCTZ | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| January 18, 2018 | BLEOMYCIN FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2018 | BLEOMYCIN FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2018 | LEVOTHYROXINE SODIUM FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | RUMENSIN CRC | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 18, 2018 | NOVODRY PLUS | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | PENAQUA SOL-G | Bimeda-MTC Animal Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2018 | POT-PEN | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | PENICILLIN G PROCAINE 110 | Bio Agri Mix Lp | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | PROPEN LA | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | SUSTAIN III | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | RACTOPAMINE 4 | Bio Agri Mix Lp | New Drug Submission (NDS) · Other |
| January 18, 2018 | TYLOSIN 100 | Bio Agri Mix Lp | Abbreviated New Drug Submission (ANDS) · Other |
| January 18, 2018 | SUPER CHLOROSOL-250 | Bio Agri Mix Lp | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | SUPER CHLOR 250 | Bio Agri Mix Lp | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | AUREO S-P 250 G | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | CHLOR 250 | Bio Agri Mix Lp | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | AUREOMIX 625 G | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | PENICILLIN G POTASSIUM USP SOLUBLE POWDER | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2018 | PENICILLIN G POTASSIUM USP SOLUBLE POWDER | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2018 | POT-PEN | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | CALFSPAN TABLETS | Can-Vet Animal Health Supplies Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | CALFSTRONG TABLETS | Inland Veterinary Supply Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2018 | CHLOR 50 | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2018 | TEVA-MOMETASONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 17, 2018 | RASILEZ HCT | Noden Pharma Dac | New Drug Submission (NDS) · Admin |
| January 17, 2018 | APO-PRAMIPEXOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2018 | ADVIL COLD, SINUS & FLU EXTRA STRENGTH | Pfizer Consumer Healthcare, a division of Pfizer Canada ULC | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2018 | GANCICLOVIR FOR INJECTION USP | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 16, 2018 | MED-MOXIFLOXACIN | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 16, 2018 | IPRAVENT | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 16, 2018 | APO-ATOVAQUONE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 16, 2018 | STRESNIL | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| January 15, 2018 | TETRAJECT LA | Bimeda-MTC Animal Health Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | ULTIBRO BREEZHALER | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | PANTOPRAZOLE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 15, 2018 | TEVA-RISEDRONATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 15, 2018 | PANTOPRAZOLE SODIUM FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 15, 2018 | APO-ATENOL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | LORAZEPAM SUBLINGUAL | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| January 15, 2018 | TETRAJECT LP | Bimeda-MTC Animal Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 15, 2018 | TETRAJECT LA | Mtc Pharmaceuticals | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | OXYTETRAMYCIN 100 | Dominion Veterinary Laboratories Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | TRESADERM | Merial Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | OXYVET 100 LP | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | OXYVET 200 LA | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | OXYVET 300 LA | Norbrook Laboratories Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | TERRAMYCIN - AQUA | Phibro Animal Health Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | OXYMYCINE LA | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | OXYMYCINE LA 300 | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | OXYMYCINE LP | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | OXY LA | Citadel Animal Health | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | OXY LP | Citadel Animal Health | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | ALAMYCIN LA | Norbrook Laboratories Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | BIO-MYCIN 200 | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | COMPUDOSE | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | CYCLOSOL 200 LA | Eurovet Animal Health B V | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 15, 2018 | KELAMYCIN INTRAUTERINE SUSPENSION | Wendt Labs | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | LIQUAMYCIN LA-200 | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | NOROMYCIN LA | Norbrook Laboratories Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | NOROMYCIN LA 300 | Norbrook Laboratories Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2018 | NOROMYCIN LP | Norbrook Laboratories Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2018 | BORTEZOMIB FOR INJECTION | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2018 | RASILEZ | Noden Pharma Dac | New Drug Submission (NDS) · Admin |
| January 12, 2018 | PMS-ALLOPURINOL | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 12, 2018 | RACTOPAMINE 20 | Bio Agri Mix Lp | Abbreviated New Drug Submission (ANDS) · Other |
| January 11, 2018 | BACLOFEN INJECTION | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 11, 2018 | ORABLOC 1:100,000; ORABLOC 1:200,000 | Pierrel Pharma S.R.L. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 11, 2018 | TEVA-SPIRONOLACTONE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2018 | TEVA-SPIRONOLACTONE/HCTZ | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2018 | CARBOPLATIN INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2018 | WINRHO SDF | Saol Therapeutics Research Limited | New Drug Submission (NDS) · Admin |
| January 11, 2018 | LINCOMIX 100 | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2018 | LINCOMIX 110 | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2018 | LINCOMIX 44 | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2018 | LINCOMYCIN 110 G | Bio Agri Mix Lp | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2018 | LINCOMYCIN 110 | Bio Agri Mix Lp | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2018 | LINCOMYCIN 44 G | Bio Agri Mix Lp | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2018 | LINCOMYCIN 44 | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2018 | LINXMED-SP | Bimeda-MTC Animal Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2018 | SPECTAM SCOUR-HALT | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2018 | L-S 20 | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2018 | LINCO-SPECTIN 100 | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2018 | LINCOMYCIN SPECTINOMYCIN 100 SOLUBLE POWDER | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2018 | LINCOMYCIN SPECTINOMYCIN 4.4% G PREMIX | Bio Agri Mix Lp | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2018 | LINCO-SPECTIN | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2018 | LINCOMED 100 | Bimeda-MTC Animal Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 10, 2018 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 10, 2018 | TRISENOX | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| January 10, 2018 | TREANDA | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| January 10, 2018 | EZETIMIBE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| January 10, 2018 | MYLAN-TRANDOLAPRIL | Mylan Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| January 10, 2018 | JAKAVI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 10, 2018 | ACH-FINASTERIDE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 10, 2018 | OVUGEL | Jbs United Animal Health Ii Llc | New Drug Submission (NDS) · Admin |
| January 9, 2018 | TYLOSIN 40 | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2018 | PRAMIPEXOLE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 9, 2018 | TEVA-CARVEDILOL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 9, 2018 | DOXEPIN | AA Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| January 9, 2018 | SEVOFLURANE | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2018 | AURO-AMOXICLAV | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 8, 2018 | COMPONENT TE-100 IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2018 | COMPONENT E-C IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2018 | PHARMASIN 100 | Huvepharma Eood | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 8, 2018 | PHARMASIN SOLUBLE | Huvepharma Eood | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 8, 2018 | TYLAN 200 | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2018 | TYLAN SOLUBLE | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2018 | TYLOSIN 10 | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 8, 2018 | TYLOSIN SOLUBLE POWDER | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 8, 2018 | COMPONENT TE-200 IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2018 | COMPONENT TE-G IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2018 | COMPONENT TE-H IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2018 | COMPONENT TE-S IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2018 | COMPONENT E-H IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2018 | COMPONENT E-S IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2018 | DERMA-SMOOTHE/FS TOPICAL OIL | Hill Dermaceuticals, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2018 | TEMAZEPAM | AA Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| January 5, 2018 | VELPHORO | Vifor Fresenius Medical Care Renal Pharma Ltd | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 5, 2018 | AURO-ATOMOXETINE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 5, 2018 | SURVANTA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2018 | SOLIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2018 | OZEMPIC | Novo Nordisk Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 4, 2018 | LUPRON DEPOT | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2018 | LUPRON; LUPRON DEPOT | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2018 | ROCURONIUM BROMIDE INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 4, 2018 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 21; DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 28 | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 4, 2018 | DIAMICRON MR | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2018 | MINT-EPLERENONE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| January 4, 2018 | PULMOTIL PREMIX | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2018 | TILMICOSIN 200 | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2018 | APRALAN | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2018 | AIVLOSIN 17% | Eco Animal Health Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2018 | TILMOVET PREMIX | Huvepharma Eood | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 3, 2018 | M-ESCITALOPRAM | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 3, 2018 | M-CLARITHROMYCIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 3, 2018 | ACT DUTASTERIDE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| January 3, 2018 | RIVA-OLMESARTAN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 3, 2018 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Teligent Ou | Abbreviated New Drug Submission (ANDS) · Admin |
| January 3, 2018 | RAPIVAB | Biocryst Pharmaceuticals Inc | New Drug Submission (NDS) · Admin |
| January 3, 2018 | METOJECT SUBCUTANEOUS | Medexus Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 3, 2018 | MOSASPRAY | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 3, 2018 | SOFRACORT STERILE EAR/EYE DROPS | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 3, 2018 | ENZAPROST T | Ceva Animal Health Inc | Abbreviated New Drug Submission (ANDS) · Other |
| January 2, 2018 | XIAFLEX | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 2, 2018 | IRBESARTAN-HCTZ | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| January 2, 2018 | GLN-TOPIRAMATE | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |